The potential role of prostaglandin D2 in nasal congestion observed in a guinea pig model of allergic rhinitis

International Archives of Allergy and Immunology

Volumn 158, Issue 4, 2012, Pages 359-368

  Takahashi, Go ^a,c   Tanaka, Hiroyuki ^a,b   Higuchi, Naoko ^c   Ikeda, Minoru ^c   Inagaki, Naoki ^a,b   Shichijo, Michitaka ^c  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

Allergic rhinitis; cAMP; Nasal congestion; Prostaglandin D2; Prostanoid DP 1 receptor

Indexed keywords

PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; S 5751; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GUINEA PIG; MALE; MICROVASCULATURE; NONHUMAN; NOSE AIRFLOW; NOSE CONGESTION; NOSE MUCOSA; PRESSURE; PRIORITY JOURNAL; VASODILATATION;

ANIMALS; CYCLIC AMP; DISEASE MODELS, ANIMAL; GUINEA PIGS; MALE; NASAL MUCOSA; NASAL OBSTRUCTION; PROSTAGLANDIN D2; RECEPTORS, PROSTAGLANDIN; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84859111642     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000334555     Document Type: Article

References (37)

1. Taylor-Clark T, Foreman J: Histamine-mediated mechanisms in the human nasal airway. Curr Opin Pharmacol 2005; 5: 214-220. (Pubitemid 40674241)
2. Nathan RA: The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis. Clin Ther 2008; 30: 573-586. (Pubitemid 351680497)
3. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ 2nd: Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982; 129: 1627-1631. (Pubitemid 12031103)
4. Holgate ST, Burns GB, Robinson C, Church MK: Anaphylactic-and calcium-dependent generation of prostaglandin D2, thromboxane B2, and other cycooxgenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol 1984; 133: 2138-2144. (Pubitemid 14035322)
5. Gundel RH, Kinkade P, Torcellini CA, Clarke CC, Watrous J, Desai S, Homon CA, Farina PR, Wegner CD: Antigen-induced mediator release in primates. Am Rev Respir Dis 1991; 144: 76-82.
6. Murray JJ, Tonnel AB, Brash AR, Roberts LJ 2nd, Gosset P, Workman R, Capron A, Oates JA: Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986; 315: 800-804. (Pubitemid 16014343)
7. Johnston SL, Freezer NJ, Ritter W, O'Toole S, Howarth PH: Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. Eur Respir J 1995; 8: 411-415.
8. Woodward DF, Nieves AL, Friedlaender MH: Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritis and their role in mediating allergic conjunctival itching. J Pharmacol Exp Ther 1996; 279: 137-142. (Pubitemid 27166904)
9. Cheng K, Wu TJ, Wu KK, Sturino C, Metters K, Gottesdiener K, Wright SD, Wang Z, O'Neill G, Lai E, Waters MG: Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci USA 2006; 103: 6682-6687.
10. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M: Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 1995; 270: 18910-18916.
11. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K: Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001; 193: 255-261. (Pubitemid 32524457)
12. Heinemann A, Schuligoi R, Sabroe I, Hartnell A, Peskar BA: 12-prostaglandin J2, a plasma metabolite of prostaglandin D2 causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003; 170: 4752-4753.
13. Hata AN, Breyer RM: Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 2004; 103: 147-166. (Pubitemid 39209041)
14. Luster AD, Tager AM: T cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 2004: 4:711-724. (Pubitemid 39223077)
15. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD: Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001; 41: 661-690. (Pubitemid 32385902)
16. Arimura A, Yasui K, Kishino J, Asanuma F, Hasegawa H, Kakudo S, Ohtani M, Arita H: Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. J Pharmacol Exp Ther 2001; 298: 411-419. (Pubitemid 32673391)
17. Yasui K, Asanuma F, Hirano Y, Shichijo M, Deguchi M, Arimura A: Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed antigen. Eur J Phamacol 2008; 578: 286-291. (Pubitemid 350309580)
18. Doyle WJ, Boehm S, Skoner DP: Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990; 86: 924-935.
19. Van Hecken A, Depré M, De Lepeleire I, Thach C, Oeyen M, Van Effen J, Laethem T, Mazina K, Crumley T, Wenning L, Gottesdiener KM, Deutsch P, Clement P, Lai E, de Hoon JN: The effect of MK-0524, a prostaglandin D(2) receptor antagonist, on prostaglandin D(2)-induced nasal airway obstruction in healthy volunteers. Eur J Clin Pharmacol 2007; 63: 135-141. (Pubitemid 46147054)
20. Andersson P: Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs. The effect of booster injection and cyclophosphamide treatment. Int Arch Allergy Appl Immunol 1981; 64: 249-258. (Pubitemid 11153157)
21. Pennock BE, Cox CP, Rogers RM, Cain WA, Wells JH: A noninvasive technique for measurement of changes in specific airway resistance. J Appl Physiol 1979; 46: 399-406. (Pubitemid 9158788)
22. Chiba Y, Matsuo K, Sakai H, Abe K, Misawa M: Regional differences in vascular responsiveness of nasal mucosae isolated from naive guinea pigs. Auris Nasus Larynx 2007; 34: 197-201. (Pubitemid 46603222)
23. Bellows CF, Alder A, Wludyka P, Jaffe BM: Modulation of macrophage nitric oxide production by prostaglandin D2. J Surg Res 2006; 132: 92-97.
24. Braun M, Schrör K: Prostaglandin D2 relaxes bovine coronary arteries by endotheliumdependent nitric oxide-mediated cGMP formation. Circ Res 1992; 71: 1305-1313.
25. Lee SL, Levitsky S, Feinberg H: Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction. J Phamacol Exp Ther 1991; 258: 292-298.
26. Kamanna VS, Ganji SH, Kashyap ML: The mechanism and mitigation of niacin-induced flushing. Int J Clin Pract 2009; 63: 1369-1377.
27. Hochban W, Althoff H, Ziegler A: Nasal decongestion with imidazoline derivatives: acoustic rhinometry measurements. Eur J Clin Phamacol 1999; 55: 7-12. (Pubitemid 29144093)
28. Mizutani N: Studies on the experimental allergic rhinitis induced by Japanese cedar pollen-role of cysteinyl leukotrienes in nasal allergic symptoms. Yakugaku Zasshi 2003; 123: 1-8. (Pubitemid 41359102)
29. Hirano Y, Shichijo M, Ikeda M, Kitaura M, Tsuchida J, Asanuma F, Yanagimoto T, Furue Y, Imura K, Arimura A: Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats. Eur J Pharmacol 2011; 666: 233-241.
30. Watanabe H, Tsuru H: Microcirculation in the nasal mucosa. Nippon Yakurigaku Zasshi 1999; 113: 211-218. (Pubitemid 29169365)
31. Ichimura K, Jackson RT: Evidence of alpha 2-adrenoceptors in the nasal blood vessels of the dog. Arch Otolaryngol 1984; 110: 647-651. (Pubitemid 14008108)
32. Nantel F, Fong C, Lamontagne S, Wright DH, Giaid A, Desrosiers M, Metters KM, O'Neill GP, Gervais FG: Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat 2004; 73: 87-101. (Pubitemid 38450719)
33. Unno T, Baba S, Nakajima K, Takasaka T, Togawa K, Baba K, Sakakura Y, Ishikawa T, Matsuzaki T: Effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal obstruction in patients with perennial allergic rhinitis. J Clin Ther Med 1996; 12: 2593-2611.
34. Persson CG: Plasma exudation in tracheobronchial and nasal airway: a mucosal defence mechanism becomes pathogenic asthma and rhinitis. Eur Respir J Suppl 1990; 12: 652s-657s.
35. Naclerio RM, Baroody FM, Togias AG: The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis 1991; 143:S91-S95.
36. Atkinson TP, Kaliner MA: Vascular mechanisms in rhinitis; in Busse WW, Holgate ST (eds): Asthma and Rhinitis. Boston, Blackwell Scientific, 1995, pp 777-788.
37. Smedegard G, Bjork J, Arfors KE: An intravital microcsopy model for studies of immune complex induced inflammation at the microvasculuar level. Int J Tissue React 1985; 7: 55-60. (Pubitemid 15109360)